1 palmitoyl 2 hydroxy sn glycero 3 pe

1-Palmitoyl-2-hydroxy-sn-glycero-3-PE is a naturally occurring lysophospholipid and endogenous metabolite used in biochemical experiments and drug synthesis research.

1-Palmitoyl-2-hydroxy-sn-glycero-3-PE-d31 is a deuterium-labeled version of 1-Palmitoyl-2-hydroxy-sn-glycero-3-PE. The compound, a naturally occurring choline phospholipid, can be synthesized from phosphatidylcholine and fatty acids. It serves as a structural-related lipid control.

1-Palmitoyl-D9-2-hydroxy-sn-glycero-3-PE serves as an internal standard for quantifying 1-palmitoyl-2-hydroxy-sn-glycero-3-PE, a lysophospholipid naturally found to inhibit L. donovani promastigotes growth (GI50= 8 µM). Its levels are reduced in mice after alcohol-induced liver damage, in hepatocellular carcinoma mouse xenografts, and in humans following a rigorous three-day exercise regimen of 2.5 hours running daily and 14 hours post-regimen. This compound is also applied in measuring saturated lysophosphoethanolamines, highlighting its broad utility in biochemical research and disease model studies.

1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol)-d31ammonium (1-Palmitoyl-2-hydroxy-sn-glycero-3-PG-d31ammonium) is a deuterium-labeled form of 1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) ammonium. This compound, 1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (16:0 Lyso PE) sodium, is a lysophospholipid containing palmitic acid (16:0) at the sn-1 position. It is applicable in the formation of micelles, liposomes, and other artificial membranes, including lipid-based drug delivery systems.